Concepedia

Lili Zhu

LZ

Statistics

Publications

23

Citations

913

H-Index

18

Active since

1998

Affiliations

East China University of Science and Technology(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

Wuhan Institute of Virology

University of Chinese Academy of Sciences

Lili Zhu is an author at East China University of Science and Technology specializing in pharmacology, drug discovery, and medicine.

ORCID

Publications per year

1998–2024

23

Publications

23

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Rui Xiong, Leike Zhang, Shiliang Li et al. · Protein & Cell · 2020 · 209 citations · Full text

, , +16

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2

Wenhao Dai, Dirk Jochmans, Hang Xie et al. · Journal of Medicinal Chemistry · 2021 · 89 citations · Full text

, , +17

Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein

Lin Wang, Yan Wu, Sheng Yao et al. · Acta Pharmacologica Sinica · 2021 · 75 citations · Full text

, , +9

Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR<sup>L858R/T790M/C797S</sup>

Qiannan Li, Tao Zhang, Shiliang Li et al. · ACS Medicinal Chemistry Letters · 2019 · 65 citations · Full text

, , +16

ASPM promotes hepatocellular carcinoma progression by activating Wnt/β‐catenin signaling through antagonizing autophagy‐mediated Dvl2 degradation

Haifeng Zhang, Xiaobei Yang, Lili Zhu et al. · FEBS Open Bio · 2021 · 49 citations · Full text

, , +17

1–5 of 23